Cardea Bio Takes In $6.5M More In Series A
socalTECH
JANUARY 12, 2021
San Diego-based Cardea Bio, a startup that is developing molecular biology equipment which uses semiconductors to analyze samples, said on Tuesday that it has raised $6.5M The company said the new funding was led by 3E Bioventures Capital, and also included existing investors. more in its Series A funding.
Let's personalize your content